Breakthroughs in long-acting treatments and gene-based therapies are revolutionizing patient care, leading to improved adherence and better health outcomes. Moreover, advancements in diagnostic capabilities and the bolstering of healthcare infrastructure—particularly in North America and Europe—are fueling this market's expansion.